Cleveland Clinic Lou Ruvo Center for Brain Health Las Vegas Nevada
.jpg)
Lou Ruvo Brain Center - Working Together to Fight Alzheimer’s
This month I continue covering the Cleveland Clinic Lou Ruvo Center for Brain Health. Recall last month a new Director was appointed. This month the Center is emphasizing its progress and plans for future progress.
Some perspective: There are 5.3 million Americans with Alzheimer’s disease (including 29,000 Nevadans). This number is estimated to reach 16 million by 2050. September 21 is World Alzheimer's Day – a day when the Alzheimer's Association joins with organizations and people around the globe to raise awareness about Alzheimer's and its impact on our families, communities and nations. Today, 35 million people worldwide are affected by Alzheimer's and related dementias, and this number is growing rapidly. World Alzheimer's Day is an opportunity to raise awareness about Alzheimer's disease and the need for more education, support and research.
The Lou Ruvo Center, located in downtown Las Vegas is consistently performing clinical studies and reaches out to all volunteers to help. Education is the goal, Jeffrey Cummings, a medical director at Lou Ruvo Center for Brain Health explains, “Patients must participate in trials if there is to be any progress in developing new treatments for Alzheimer’s disease. Trials are critically important partnerships among patients and families, doctors and scientists to advance new treatments for the Alzheimer’s disease.” Las Vegas Sun Sept. 19, 2010.
The Lou Ruvo Center for Brain Health has been in various stages of opening as construction was completed and is now fully operational. World Alzheimer’s day is September 21 and The Center announces it has great plans and hopes for finding a cure. And of course this gives Las Vegas some notoriety in the field of medicine – something most would agree is sorely needed.
First, While most previous drugs have failed, the drugs being tested today are based on years old science (it takes 7 to 10 years for a drug to be approved by the FDA) Since we now have a better understanding of which proteins damage the brain (build up of a toxic peptide called beta amyloid) we can be more focused. (See my post on July 15, 2009.)
Second, newer and better brain imaging technology and spinal fluid tests significantly affect drug development. This is revolutionizing the way we think about Alzheimer’s disease. These new imaging techniques give researchers a clearer picture of those likely to develop Alzheimer’s later in life at an earlier age.
Third, early diagnosis is a major goal. Since we are able to detect disease onset sooner, a patient may still make crucial decisions regarding care and more while their faculties are still more or less intact. Participation in health care and other life decisions prior to intellectual decline is an important aspect of any patient’s care.
If you are interested in participating in clinical trials contact Cleveland Clinic’s Lou Ruvo Center for Brain Health by clicking here.
.jpg)
xpectations of the public who drive on the roads with these trucks. An attorney must be not only familiar with these regulations but fluent in them.
